Promising Phase 2 Results for Myasthenia Gravis Med
Intravenous nipocalimab provides clinical benefits for patients with generalized myasthenia gravis, an IgG autoantibody-mediated disease characterized by muscle weakness.
Source: medscape.com
Stay updated with breaking news from Carlo Antozzi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Intravenous nipocalimab provides clinical benefits for patients with generalized myasthenia gravis, an IgG autoantibody-mediated disease characterized by muscle weakness.